The function of the Protein Production Shared Resource (PPSR) is to stimulate and support interdisciplinary research among Cancer Center members and translate discoveries in the molecular and cellular biology of cancer to the disciplines of biochemistry, structural biology and chemical biology. The importance of protein science in Cancer Center research will grow in the post-genomic era. Pure proteins are essential for progress and the Protein Production Shared Resource is a focus of expertise and equipment for providing Cancer Center investigators at St. Jude Cancer Center access to these vital reagents. The PPSR employs state-ofthe- art technology to produce proteins and protein domains in large quantities for detailed biochemical and structural analysis. Efficient protein purification is facilitated by contemporary high-resolution chromatography systems, and the facility is equipped with automated crystallization screening equipment. The PPSR services are divided into four modules: (a) subcloning open reading frames into expression vectors; (b) expression of tagged proteins in a bacterial system; purification of the protein product; and (d) preliminary crystallization trials. We accept genes cloned into an appropriate vector for expression in bacterial systems. The protein is then purified by affinity, size exclusion and/or anion exchange chromatography. Crystallization trials are initiated using a CyberLab Robotic workstation. Crude extracts may also be submitted for purification of the protein of interest, or a pure protein submitted for crystallization trials. The resource is designed to be a high throughput facility, focused on performing achievable goals. The projected total budget for this Shared Resource in Year-25 of this grant is $426,268, of which 26% ($112,053) is requested from the CCSG; the remainder of the budget (74%, $314,215) will be provided by SJCRH institutional funds and by chargeback to individual investigators. Essentially >95% of the usage of this Shared Resource is by Cancer Center members, and the great majority of their usage (90%) is for peer-reviewed funded projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-25S1
Application #
6610701
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-06-24
Project End
2007-02-28
Budget Start
Budget End
Support Year
25
Fiscal Year
2002
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Nishii, Rina; Moriyama, Takaya; Janke, Laura J et al. (2018) Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy. Blood 131:2466-2474
Fernandez-Pineda, Israel; Davidoff, Andrew M; Lu, Lu et al. (2018) Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 65:e27232
Stewart, Elizabeth; McEvoy, Justina; Wang, Hong et al. (2018) Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses. Cancer Cell 34:411-426.e19
Broniscer, Alberto; Hwang, Scott N; Chamdine, Omar et al. (2018) Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts. Brain Pathol 28:112-120
Wogksch, Matthew D; Howell, Carrie R; Wilson, Carmen L et al. (2018) Physical fitness in survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort. Pediatr Blood Cancer :e27506
Halalsheh, Hadeel; Kaste, Sue C; Navid, Fariba et al. (2018) The role of routine imaging in pediatric cutaneous melanoma. Pediatr Blood Cancer 65:e27412
Wang, Lu; Hiler, Daniel; Xu, Beisi et al. (2018) Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures. Cell Rep 22:2601-2614
Vanarotti, Murugendra; Evison, Benjamin J; Actis, Marcelo L et al. (2018) Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance. Bioorg Med Chem 26:2345-2353
Quinn, Melissa; Fannin, J T; Sciasci, Joseph et al. (2018) Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy. Antimicrob Agents Chemother 62:
Brinkman, Tara M; Recklitis, Christopher J; Michel, Gisela et al. (2018) Psychological Symptoms, Social Outcomes, Socioeconomic Attainment, and Health Behaviors Among Survivors of Childhood Cancer: Current State of the Literature. J Clin Oncol 36:2190-2197

Showing the most recent 10 out of 6764 publications